Basic income (loss) per share is computed by dividing our net income (loss) by the weighted average number of shares of our Common Stock outstanding during the period. Shares of Common Stock outstanding under the share lending arrangement entered into in conjunction with the 2025 Notes (as defined in Note 7) have been excluded from the calculation of basic and diluted earnings per share because the borrower of the shares was required under the share lending arrangement to refund any dividends paid on the shares lent. We terminated the share lending agreement on January 22, 2024. For diluted earnings per share, the dilutive impact of stock options and warrants is determined by applying the “treasury stock” method. The dilutive impact of the 2029 Convertible Notes, 2033 Senior Notes, the 2023 Convertible Notes and the 2025 Notes (each, as defined and discussed in Note 7) has been considered using the “if converted” method. For periods in which their effect would have been antidilutive, no effect is given in the dilutive computation to Common Stock issuable under outstanding options or warrants or the potentially dilutive shares issuable pursuant to the 2029 Convertible Notes, 2033 Senior Notes, the 2023 Convertible Notes and the 2025 Notes. The following table sets forth the computation of basic and diluted income (loss) per share:


	For the three months ended September 30,
(In thousands, except per share data)	2025		2024
Numerator
Net income (loss), basic	$	21,631	$	24,890
Add: Interest on 2025 Notes		-		1
Add: Interest on 2029 Convertible Notes		-		6,858
Add: Loss on buy back of 2029 Convertible Notes		-		32
Net income (loss), diluted	$	21,631	$	31,781

Denominator
(Shares in thousands)
Weighted average common shares outstanding, basic		777,154,808		694,622,466
Effect of dilutive securities:
Stock options		2,764,451		76,922
2025 Notes		-		48,295
2033 Senior Notes		-		8,489
2029 Convertible Notes		-		303,607,464
Dilutive potential shares		2,764,451		303,741,170

Weighted average common shares outstanding, diluted		779,919,259		998,363,636

Income (loss) per share, basic	$	0.03	$	0.04
Income (loss) per share, diluted	$	0.03	$	0.03

A total of 105,548,111 potential shares of Common Stock, of which 105,541,737 related to the 2029 Convertible Notes, were excluded from the calculation of diluted net loss per share for the three months ended September 30, 2025, because their inclusion would have been antidilutive.

A total of 165,834,223 and 286,281,585 potential shares of Common Stock were excluded from the calculation of diluted net loss per share for the nine months ended September 30, 2025 and 2024, respectively, because their inclusion would have been antidilutive.

During the three months ended September 30, 2025, no options were exercised, and no restricted stock units vested.

During the nine months ended September 30, 2025, 57,500 options were exercised, and 553,822 restricted stock units vested.

During the three months ended September 30, 2024, no options were exercised, and no restricted stock units vested, resulting in the issuance of no shares of Common Stock.

During the nine months ended September 30, 2024, no options were exercised, and 549,687 restricted stock units vested, resulting in the issuance of 384,378 shares of Common Stock.